Document is current
Any future updates will be listed below
-
Authors
Huynh-Le, Minh-Phuong https://orcid.org/0000-0002-5025-4709
Fan, Chun Chieh https://orcid.org/0000-0001-9437-2128
Karunamuni, Roshan
Thompson, Wesley K.
Martinez, Maria Elena
Eeles, Rosalind A. https://orcid.org/0000-0002-3698-6241
Kote-Jarai, Zsofia
Muir, Kenneth https://orcid.org/0000-0001-6429-988X
Schleutker, Johanna https://orcid.org/0000-0002-1863-0305
Pashayan, Nora https://orcid.org/0000-0003-0843-2468
Batra, Jyotsna https://orcid.org/0000-0003-4646-6247
Grönberg, Henrik https://orcid.org/0000-0002-1073-2753
Neal, David E.
Donovan, Jenny L.
Hamdy, Freddie C.
Martin, Richard M. https://orcid.org/0000-0002-7992-7719
Nielsen, Sune F.
Nordestgaard, Børge G. https://orcid.org/0000-0002-1954-7220
Wiklund, Fredrik https://orcid.org/0000-0002-4623-0544
Tangen, Catherine M.
Giles, Graham G. https://orcid.org/0000-0003-4946-9099
Wolk, Alicja https://orcid.org/0000-0001-7387-6845
Albanes, Demetrius
Travis, Ruth C. https://orcid.org/0000-0002-9571-0763
Blot, William J.
Zheng, Wei https://orcid.org/0000-0003-1226-070X
Sanderson, Maureen
Stanford, Janet L.
Mucci, Lorelei A.
West, Catharine M. L. https://orcid.org/0000-0002-0839-3449
Kibel, Adam S.
Cussenot, Olivier
Berndt, Sonja I.
Koutros, Stella
Sørensen, Karina Dalsgaard https://orcid.org/0000-0002-4902-5490
Cybulski, Cezary
Grindedal, Eli Marie
Menegaux, Florence
Khaw, Kay-Tee
Park, Jong Y. https://orcid.org/0000-0002-6384-6447
Ingles, Sue A.
Maier, Christiane
Hamilton, Robert J.
Thibodeau, Stephen N.
Rosenstein, Barry S.
Lu, Yong-Jie
Watya, Stephen
Vega, Ana https://orcid.org/0000-0002-7416-5137
Kogevinas, Manolis
Penney, Kathryn L.
Huff, Chad
Teixeira, Manuel R. https://orcid.org/0000-0002-4896-5982
Multigner, Luc https://orcid.org/0000-0003-3205-8568
Leach, Robin J.
Cannon-Albright, Lisa https://orcid.org/0000-0003-2602-3668
Brenner, Hermann
John, Esther M.
Kaneva, Radka
Logothetis, Christopher J.
Neuhausen, Susan L.
De Ruyck, Kim
Pandha, Hardev
Razack, Azad
Newcomb, Lisa F.
Fowke, Jay H.
Gamulin, Marija https://orcid.org/0000-0003-2431-7910
Usmani, Nawaid
Claessens, Frank
Gago-Dominguez, Manuela
Townsend, Paul A.
Bush, William S. https://orcid.org/0000-0002-9729-6519
Roobol, Monique J. https://orcid.org/0000-0001-6967-1708
Parent, Marie-Élise
Hu, Jennifer J.
Mills, Ian G.
Andreassen, Ole A. https://orcid.org/0000-0002-4461-3568
Dale, Anders M.
Seibert, Tyler M. https://orcid.org/0000-0002-4089-7399
,
,
,
,
,
,
,
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (K08EB026503)
- License Information
-
More Information
Article History
Received: 15 May 2020
Accepted: 12 January 2021
First Online: 23 February 2021
Competing interests
: A.M. Dale and T.M. Seibert report a research grant from the US Department of Defense. O.A. Andreassen reports research grants from K.G. Jebsen Stiftelsen, Research Council of Norway, and South East Norway Health Authority. N. Usmani reports grants from Astra Zeneca and Astellas, research collaboration, and financial in-kind support from Best Medical Canada and Concure Oncology. R.M. Martin reports grants from Cancer Research UK, during the conduct of the study. K.D. Sørensen reports grants from Danish Cancer Society, grants from Velux Foundation, during the conduct of the study. T.M. Seibert reports honoraria from Multimodal Imaging Services Corporation for imaging segmentation and honoraria from Varian Medical Systems and WebMD, Inc. for educational content. A.S. Kibel reports advisory board memberships for Sanofi-Aventis, Dendreon, and Profound. R.A. Eeles reports honoraria from GU-ASCO, honoraria/speaker fees from Janssen, honoraria from an invited talk to the University of Chicago, and educational honoraria from Bayer&Ipsen. K.D. Sørensen reports personal fees from AstraZeneca, personal fees from Sanofi, outside the submitted work. N. Usmani reports honoraria from Janssen Canada and Bayer, outside the submitted work. M. Gamulin reports speaker/advisor board/travel fees for BMS, Pfizer, Novartis, Astellas, Sanofi, Janssen, Roche, Sandoz, Amgen, Bayer, PharmaSwiss, MSD, Alvogen. M. Gamuli also reports non-financial report for drugs from BMS, Roche, Janssen. A.M. Dale has additional disclosures outside the present work: founder, equity holder, and advisory board member for CorTechs Labs, Inc.; advisory board member of Human Longevity, Inc.; recipient of nonfinancial research support from General Electric Healthcare. K.D. Sørensen is co-inventor on an issued patent (“Biomarkers for prostate cancer”/# US10106854B2, # AU2013275761B2, # JP6242388B2) licensed to Qiagen, on an issued patent (“A microRNA-based method for early detection of prostate cancer in urine samples”/# US10400288B2, # EP3256602B1, # ES2749651T3) licensed to Qiagen, and on an issued patent (“A microRNA-based method for assessing the prognosis of a prostate cancer patient”/# US10358681B2, # EP3262186B1, # ES2724404T3, #JP6769979B2), licensed to Qiagen. N. Usmani has a patent (US Provisional Patent Application No. 62/688,481: “Theranostic radiophotodynamic therapy nanoparticles”) pending, and a patent (US Patent Application No. 15/978,996: “Hand-held device and computer-implemented system and method for assisted steering of a percutaneously inserted needle”) pending. The remaining authors declare no competing interests. Additional acknowledgments for the PRACTICAL consortium and contributing studies are described in the Supplemental Material.
